Webb P M, Yu M C, Forman D, Henderson B E, Newell D G, Yuan J M, Gao Y T, Ross R K
ICRF Cancer Epidemiology Unit, Radcliffe Infirmary, Oxford, UK.
Int J Cancer. 1996 Sep 4;67(5):603-7. doi: 10.1002/(SICI)1097-0215(19960904)67:5<603::AID-IJC2>3.0.CO;2-Y.
Several prospective studies have shown a significant association between Helicobacter pylori seropositivity and the risk of gastric cancer. Only a small proportion of H. pylori-infected individuals will, however, develop gastric cancer, and it is unclear what effects other factors, such as diet, might have on the risk of cancer. Eighty-seven subjects with gastric cancer were identified during the first 6 years of follow-up (mean 2.4 years) of a cohort of middle-aged men from Shanghai, China. They were matched with 261 cancer-free controls, and serum samples from all subjects, obtained at recruitment, were assayed for anti-H. pylori IgG antibodies. Questionnaire data provided information on a wide range of socio-demographic life-style and dietary variables. H. pylori seropositivity rates in the cases and controls were 54% and 56%, respectively. Neither the overall risk of developing gastric cancer nor the risk of developing non-cardia gastric cancer was significantly associated with prior M. pylori seropositivity. Adjustment for any of the other medical, dietary or life-style variables studied had little effect on the risk of developing non-cardia gastric cancer; simultaneous adjustment for all of these factors yielded an odds ratio of 1.17. The results do not support the hypothesis that H. pylori plays a role in the process of gastric carcinogenesis in China. It is possible that this is an artefact resulting from the relatively short follow-up period to date.
多项前瞻性研究表明,幽门螺杆菌血清阳性与胃癌风险之间存在显著关联。然而,只有一小部分幽门螺杆菌感染个体最终会患胃癌,目前尚不清楚饮食等其他因素对患癌风险会产生何种影响。在中国上海的一组中年男性队列的随访期头6年(平均2.4年)中,共识别出87名胃癌患者。将他们与261名无癌对照者进行匹配,并对所有受试者在招募时采集的血清样本检测抗幽门螺杆菌IgG抗体。问卷调查数据提供了有关广泛社会人口学、生活方式和饮食变量的信息。病例组和对照组的幽门螺杆菌血清阳性率分别为54%和56%。既往幽门螺杆菌血清阳性与患胃癌的总体风险或患非贲门部胃癌的风险均无显著关联。对所研究的任何其他医疗、饮食或生活方式变量进行调整,对患非贲门部胃癌的风险影响不大;同时对所有这些因素进行调整得出的优势比为1.17。这些结果并不支持幽门螺杆菌在中国胃癌发生过程中起作用这一假设。这可能是由于迄今为止随访期相对较短所导致的假象。